Journal of ovarian research

J Ovarian Res · ISSN (e) 1757-2215 · 483 papers in corpus
other 2020
doi:10.1186/s13048-020-00652-5 ·PMID:32359364

BACKGROUND: MicroRNAs (miRNAs) have been implicated to play a vital role in development, differentiation, cell proliferation and apoptosis. However, which miRNAs are actually associated with endometriosis-associated ovarian cancer remains c…

observational 2020
doi:10.1186/s13048-020-00698-5 ·PMID:32828125

PURPOSE: We investigated the effect of ovary preserving surgery in early International Federation of Obstetrics and Gynecology (FIGO) stage endometrial cancer patients. METHODS: Medical records were retrospectively reviewed for 539 patient…

other 2020
doi:10.1186/s13048-020-00696-7 ·PMID:32787963

BACKGROUND: Cumulus cells (CC) encapsulate growing oocytes and support their growth and development. Transcriptomic signatures of CC have the potential to serve as valuable non-invasive biomarkers for oocyte competency and potential. The pr…

lab-animal 2020
doi:10.1186/s13048-020-00738-0 ·PMID:33243289

BACKGROUND: Exposure of oocytes to the endometrioma fluid has an adverse effect on embryonic quality. To determine whether adding transferrin and antioxidants to culture medium could counteract detrimental effects on mouse cumulus-oocyte co…

other 2019
doi:10.1186/s13048-019-0489-1 ·PMID:30728052

BACKGROUND: In ovarian endometriomas (OE), the expression statuses of various steroid hormone receptors are altered compared with their expression statuses in eutopic endometrium (EE). For example, in OE, the expressions of estrogen recepto…

observational 2019
doi:10.1186/s13048-019-0522-4 ·PMID:31128593

BACKGROUND: The antral follicle count is a marker of ovarian reserve. Follicular Output RaTe (FORT) evaluates the proportion of follicles responsive to exogenous follicle stimulating hormone (FSH) during controlled ovarian stimulation. Our …

rct 2019
doi:10.1186/s13048-019-0542-0 ·PMID:31325962

INTRODUCTION: Laparoscopic cystectomy provides more favourable outcomes as regards the recurrence and subsequent clinical pregnancy rates. It is associated with significant reduction in the ovarian reserve due to the inevitable removal of u…

observational 2019
doi:10.1186/s13048-019-0481-9 ·PMID:30678691

BACKGROUND: Ovarian clear cell carcinoma (OCCC) is the second most common ovarian cancer after serous carcinoma in Japan. OCCC has a more unfavorable clinical outcome due to a poor response to platinum-based chemotherapy, compared with sero…

review 2019
doi:10.1186/s13048-019-0503-7 ·PMID:30917847

Ovarian cancer is the 5th leading cause of death for women with cancer worldwide. In more than 70% of cases, it is only diagnosed at an advanced stage. Our study aims to give an update on the biological markers for diagnosing ovarian cancer…

review 2019
doi:10.1186/s13048-019-0528-y ·PMID:31174571

BACKGROUND: The ovary is an important organ of the female reproductive system, which produces oocytes and secretes reproductive hormones. Ovaries have complex dual blood supplies with their blood supply being the core component to protect a…

observational 2019
doi:10.1186/s13048-019-0485-5 ·PMID:30700327

OBJECTIVE: The aim of our study was to evaluate and compare the differences in the clinicopathological variables and overall survival (OS) of synchronous primary cancers of the endometrium and ovary (SCEO) and endometrial cancer with ovaria…

other 2019
doi:10.1186/s13048-019-0591-4 ·PMID:31771659

BACKGROUND: Cancer Antigen 125 (CA125) is currently the best available ovarian cancer screening biomarker. However, CA125 has been limited by low sensitivity and specificity in part due to normal variation between individuals. Personal char…

observational 2019
doi:10.1186/s13048-019-0525-1 ·PMID:31128592

INTRODUCTION: The management of Serous Tubal Intraepithelial Carcinoma (STIC) found at the time of Risk-Reducing Salpingo-Oophorectomy (RRSO) remains unclear. We set out to analyse the incidence of peritoneal carcinomas developed after prop…

meta-analysis 2019
doi:10.1186/s13048-019-0545-x ·PMID:31362769

About 80 % of all women affected by ovarian cancer present with advanced stage disease at the time of diagnosis. Achieving complete cytoreduction is complicated when many small tumor spots are found. Yet, complete cytoreduction is the most …

observational 2019
doi:10.1186/s13048-019-0572-7 ·PMID:31639028

BACKGROUND: Endometriosis patients undergoing in vitro fertilization-embryo transfer (IVF-ET) treatment suffer from lower success rates. The success of IVF-ET is related to the receptivity of the uterus and the quality of embryos, and it is…

observational 2019
doi:10.1186/s13048-019-0504-6 ·PMID:30917839

OBJECTIVES: To analyze the clinicopathological characteristics of subsequent pelvic masses after hysterectomy for benign diseases, and to compare the masses following hysterectomy with or without simultaneous bilateral salpingectomy. METHO…

other 2019
doi:10.1186/s13048-019-0587-0 ·PMID:31767040

Growing evidence indicates that the tumor biomarker cytokeratin 19 fragment (CYFRA21-1) is significant for a variety of cancers. However, its role in epithelial ovarian cancer (EOC) has rarely been reported. In this study, a receiver operat…

lab-animal 2019
doi:10.1186/s13048-019-0495-3 ·PMID:30819231

BACKGROUND: The cumulus expansion process is one of the LH mediated ovulatory processes. Hyaluronan synthase 2 (HAS2) regulates the synthesis of hyaluronic acid, the main component of the cumulus expansion process. Recently, the lncRNA HAS2…

observational 2019
doi:10.1186/s13048-019-0515-3 ·PMID:31182132

AIMS: The incidence of intraepithelial neoplasia in the fallopian tubes of women over 40 years of age who had undergone elective hysterectomy was assessed at the Aguascalientes Women's Hospital. METHODS: An observational, prospective, desc…

other 2019
doi:10.1186/s13048-019-0497-1 ·PMID:30803452

BACKGROUND: Common cancerous histological types associated with endometriosis are clear cell carcinoma (CCC) and endometrioid carcinoma (EC). CCC is regarded as an aggressive, chemoresistant histological subtype. Magnetic resonance imaging …

observational 2019
doi:10.1186/s13048-019-0539-8 ·PMID:31325966

BACKGROUND: Women with vanishing twin syndrome are associated with increased risks of adverse neonatal outcomes, such as preterm birth (PTB) and low birthweight (LBW), compared with those in singleton live births following single embryo tra…

review 2019
doi:10.1186/s13048-019-0582-5 ·PMID:31699129

Young girls before menarche or menstruating adolescent women may experience long-term drug-resistant chronic pelvic pain, as well as other symptoms associated with pelvic mass. In such cases, it is of great importance to consider ovarian en…

lab-animal 2019
doi:10.1186/s13048-019-0535-z ·PMID:31315664

BACKGROUND: Serous carcinoma, the subtype of ovarian cancer has the highest occurrence and mortality in women. Proteomic profiling using mass spectrometry (MS) has been used to detect biomarkers in tissue s obtained from patients with ovari…

review 2019
doi:10.1186/s13048-019-0530-4 ·PMID:31202269

Ovarian cancer is the main cause of death among all reproductive cancers in females. In 2018, ovarian cancer was the seventh most common cancer of women entire the world. A wide variety of molecular and genetic alterations as well as differ…

observational 2019
doi:10.1186/s13048-019-0552-y ·PMID:31470880

OBJECTIVE: To explore the risk factors for the recurrence of endometrioma and the risk factors for the recurrence of endometriosis-related pain after long-term follow-up. METHODS: This study retrospectively analyzed 358 women with endometr…